Physician profile
Yaron Elad
NPI 1841262102
$1,783.86
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $171 · 2021: $59.68 · 2022: $263 · 2023: $170 · 2024: $166 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $571.96 | 2019-2024 | Repatha |
| Medtronic, INC. | $165.79 | 2025 | Affera Mapping System |
| E.R. Squibb & Sons, L.L.C. | $164.12 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $147.92 | 2019 | |
| Heartflow, INC. | $93.04 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $87.46 | 2023-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $87.16 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $84.16 | 2019-2025 | |
| Ge Healthcare | $77.65 | 2022-2023 | |
| Pfizer INC. | $66.40 | 2023-2025 | |
| Bridgebio Pharma, INC. | $63.01 | 2025 | Attruby |
| Gilead Sciences, INC. | $49.47 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $36.46 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.59 | 2019 | |
| Edwards Lifesciences Corporation | $24.53 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.71 | 2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $18.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaron Elad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.